- Release Date: 16/07/24 08:57
- Summary: Chairman address and presentation to Scheme Meeting
- Price Sensitive: No
- Download Document 1MB
- Forums
- ASX - By Stock
- Ann: Chairman address and presentation to Scheme Meeting
Ann: Chairman address and presentation to Scheme Meeting
Featured News
Add GNX (ASX) to my watchlist
|
|||||
Last
27.3¢ |
Change
0.003(0.93%) |
Mkt cap ! $377.4M |
Open | High | Low | Value | Volume |
27.0¢ | 27.5¢ | 27.0¢ | $258.7K | 953.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
35 | 63465866 | 27.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.5¢ | 7871813 | 75 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 63465866 | 0.270 |
13 | 1790012 | 0.265 |
2 | 6600 | 0.260 |
2 | 41970 | 0.255 |
2 | 19000 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.275 | 7871813 | 75 |
0.280 | 2312858 | 16 |
0.285 | 45946 | 3 |
0.290 | 110925 | 3 |
0.295 | 124962 | 2 |
Last trade - 11.53am 16/07/2024 (20 minute delay) ? |
Featured News
GNX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online